Total planned funding: $364,303,860
Allocations
Countries/Regions
| Eswatini | $364,303,860 |
Organizational Types
| Private Contractor | $92,510,721 |
| Unknown | $73,389,386 |
| NGO | $60,682,377 |
| University | $55,875,573 |
| Own Agency | $45,904,273 |
| FBO | $13,230,009 |
| Host Country Government Agency | $10,164,978 |
| Multi-lateral Agency | $8,535,854 |
| Other USG Agency | $3,960,689 |
| Implementing Agency | $50,000 |
Program Areas
| Care | $110,527,522 |
| Treatment | $91,129,530 |
| Prevention | $68,259,679 |
| Governance and Systems | $39,891,636 |
| Testing | $28,380,728 |
| Management and Operations | $26,114,765 |
Budget Codes
| HTXS: Treatment: Adult Treatment | $73,006,550 |
| HBHC: Care: Adult Care and Support | $44,730,583 |
| HKID: Care: Orphans and Vulnerable Children | $37,953,854 |
| HVCT: Testing: HIV Testing and Counseling | $28,380,728 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $27,043,830 |
| HVMS: Management and Operations | $26,114,765 |
| CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $20,472,892 |
| HVSI: Strategic Information | $19,637,802 |
| HVTB: Care: TB/HIV | $18,548,422 |
| OHSS: Health Systems Strengthening | $14,600,903 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $10,712,159 |
| HTXD: Treatment: ARV Drugs | $10,179,456 |
| PDCS: Care: Pediatric Care and Support | $9,294,663 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $9,103,827 |
| PDTX: Treatment: Pediatric Treatment | $7,943,524 |
| HLAB: Laboratory Infrastructure | $5,652,931 |
| HMBL: Biomedical Prevention: Blood Safety | $926,971 |
| HMIN: Biomedical Prevention: Injection Safety | $0 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
Not Available:
$54,929,520
Countries/Regions
Columbia University:
$44,492,197
Countries/Regions
Pact, Inc.:
$42,003,577
Countries/Regions
Chemonics International:
$22,700,973
Countries/Regions